Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

American Journal of Perinatology

Volumn 33, Issue 5, 2016, Pages 480-485

  Procianoy, Renato S ^a   Hentges, Cláudia R ^a   Silveira, Rita C ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

angiogenesis; bronchopulmonary dysplasia; preterm neonates; respiratory distress syndrome; VEGF PlGF heterodimer

Indexed keywords

HETERODIMER; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; PGF PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANALYSIS OF VARIANCE; ARTICLE; BIRTH WEIGHT; CHI SQUARE TEST; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; KRUSKAL WALLIS TEST; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANK SUM TEST; STUDENT T TEST; UNIVARIATE ANALYSIS; BLOOD; CASE CONTROL STUDY; INFANT; INFANT MORTALITY; PROTEIN QUATERNARY STRUCTURE; VERY LOW BIRTH WEIGHT;

BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; MULTIVARIATE ANALYSIS; PLACENTA GROWTH FACTOR; PROTEIN STRUCTURE, QUATERNARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84946430339     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1566294     Document Type: Article

References (37)

1. Stroustrup A., Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics: 2010; 126 2 291 297
2. Meller S., Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res: 2012; 38 4 192 203
3. Thébaud B., Abman S. H. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med: 2007; 175 10 978 985
4. Thébaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology: 2007; 91 4 291 297
5. Muy-Rivera M., Vadachkoria S., Woelk G. B., Qiu C., Mahomed K., Williams M. A. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol Res: 2005; 54 6 611 622
6. Voelkel N. F., Vandivier R. W., Tuder R. M. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol: 2006; 290 2 L209 L221
7. Tsao P. N., Wei S. C., Chou H. C., et al. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome. Pediatr Pulmonol: 2005; 39 5 461 465
8. Yang W. C., Chen C. Y., Chou H. C., Hsieh W. S., Tsao P. N. Angiogenic factors in cord blood of preterm infants predicts subsequently developing bronchopulmonary dysplasia. Pediatr Neonatol: 2015; doi:10.1016/j.pedneo.2015.02.001
9. Ribatti D. The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis: 2008; 11 3 215 221
10. Dewerchin M., Carmeliet P. PlGF: a multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med: 2012; 2 8. doi:10.1101/cshperspect.a011056
11. Tarallo V., Tudisco L., De Falco S. A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. Am J Cancer Res: 2011; 1 2 265 274
12. Ballard J. L., Khoury J. C., Wedig K., Wang L., Eilers-Walsman B. L., Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr: 1991; 119 3 417 423
13. Alexander G. R., Himes J. H., Kaufman R. B., Mor J., Kogan M. A United States national reference for fetal growth. Obstet Gynecol: 1996; 87 2 163 168
14. Jobe A. H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med: 2001; 163 7 1723 1729
15. Hentges C. R., Silveira R. C., Ferreli R. S., Procianoy R. S. Influence of maternal pre-eclampsia on VEGF/PlGF heterodimer levels in preterm infants. J Matern Fetal Neonatal Med: 2015; 28 2166 2171
16. Ozkan H., Cetinkaya M., Koksal N. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med: 2012; 25 12 2681 2685
17. Hansen A. R., Barnés C. M., Folkman J., McElrath T. F. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr: 2010; 156 4 532 536
18. Gien J., Kinsella J. P. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr: 2011; 23 3 305 313
19. Tang J. R., Karumanchi S. A., Seedorf G., Markham N., Abman S. H. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol: 2012; 302 1 L36 L46
20. Furuya M., Kurasawa K., Nagahama K., et al. Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy: 2011; 2011 123717
21. Hentges C. R., Silveira R. C., Procianoy R. S. Angiogenic and antiangiogenic factors in preterm neonates born to mothers with and without preeclampsia. Am J Perinatol: 2015
22. Briana D. D., Malamitsi-Puchner A. Small for gestational age birth weight: impact on lung structure and function. Paediatr Respir Rev: 2013; 14 4 256 262
23. Shima Y., Kumasaka S., Migita M. Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease. Pediatr Int: 2013; 55 5 578 581
24. Eriksson A., Cao R., Pawliuk R., et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell: 2002; 1 1 99 108
25. Tarallo V., Vesci L., Capasso O., et al. A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization. Cancer Res: 2010; 70 5 1804 1813
26. Cho G. J., Roh G. S., Kim H. J., et al. Differential expression of placenta growth factors and their receptors in the normal and pregnancy-induced hypertensive human placentas. J Korean Med Sci: 2003; 18 3 402 408
27. Stefanini M. O., Wu F. TH, Mac Gabhann F., Popel A. S. A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol: 2008; 2 77
28. DiSalvo J., Bayne M. L., Conn G., et al. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J Biol Chem: 1995; 270 13 7717 7723
29. Cao Y., Chen H., Zhou L., et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem: 1996; 271 6 3154 3162
30. De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med: 2012; 44 1 1 9
31. Hadchouel A., Franco-Montoya M. L., Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol: 2014; 100 3 158 167
32. Walters E. H., Reid D., Soltani A., Ward C. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther: 2008; 118 1 128 137
33. Harkness L. M., Kanabar V., Sharma H. S., Westergren-Thorsson G., Larsson-Callerfelt A. K. Pulmonary vascular changes in asthma and COPD. Pulm Pharmacol Ther: 2014; 29 2 144 155
34. Harkness L. M., Ashton A. W., Burgess J. K. Asthma is not only an airway disease, but also a vascular disease. Pharmacol Ther: 2015; 148 17 33
35. Pałgan K., Bartuzi Z. Angiogenesis in bronchial asthma. Int J Immunopathol Pharmacol: 2015; 28 3 415 420
36. Sow F. B., Gallup J. M., Meyerholz D. K., Ackermann M. R. Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. Dev Comp Immunol: 2009; 33 6 761 771
37. Olivier A. K., Gallup J. M., van Geelen A., Ackermann M. R. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res: 2011; 37 3 131 143